DaVita (NYSE:DVA) Downgraded by StockNews.com to Hold

StockNews.com downgraded shares of DaVita (NYSE:DVAFree Report) from a buy rating to a hold rating in a research report sent to investors on Wednesday.

Other analysts also recently issued research reports about the company. Barclays boosted their price target on DaVita from $164.00 to $169.00 and gave the company an “equal weight” rating in a research note on Tuesday, February 18th. Cowen reiterated a “hold” rating on shares of DaVita in a research note on Tuesday, February 18th. Finally, Sanford C. Bernstein set a $184.00 price target on shares of DaVita in a report on Friday, February 21st. One analyst has rated the stock with a sell rating, five have issued a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $166.33.

Get Our Latest Analysis on DVA

DaVita Stock Performance

Shares of DVA opened at $154.37 on Wednesday. The company has a current ratio of 1.26, a quick ratio of 1.21 and a debt-to-equity ratio of 23.18. The firm has a market cap of $12.35 billion, a PE ratio of 14.37, a P/E/G ratio of 1.07 and a beta of 0.99. DaVita has a 12 month low of $125.64 and a 12 month high of $179.60. The stock has a fifty day moving average price of $156.49 and a 200-day moving average price of $157.41.

DaVita (NYSE:DVAGet Free Report) last issued its quarterly earnings results on Thursday, February 13th. The company reported $2.24 earnings per share for the quarter, topping the consensus estimate of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. Equities research analysts predict that DaVita will post 10.76 earnings per share for the current fiscal year.

Institutional Investors Weigh In On DaVita

Several hedge funds have recently modified their holdings of the company. Copia Wealth Management purchased a new position in shares of DaVita during the 4th quarter valued at approximately $30,000. SBI Securities Co. Ltd. acquired a new stake in shares of DaVita in the fourth quarter valued at about $41,000. Coppell Advisory Solutions LLC increased its stake in shares of DaVita by 50.0% during the fourth quarter. Coppell Advisory Solutions LLC now owns 300 shares of the company’s stock worth $45,000 after purchasing an additional 100 shares in the last quarter. Quarry LP purchased a new position in DaVita in the 3rd quarter valued at about $60,000. Finally, Canada Post Corp Registered Pension Plan acquired a new stake in DaVita in the 4th quarter worth about $55,000. 90.12% of the stock is owned by hedge funds and other institutional investors.

About DaVita

(Get Free Report)

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

Featured Articles

Analyst Recommendations for DaVita (NYSE:DVA)

Receive News & Ratings for DaVita Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita and related companies with MarketBeat.com's FREE daily email newsletter.